Clinical efficacy of Budesonide Turbuhaler in pediatric patients with bronchial asthma -Evaluation of JPAC scores and parent/guardian satisfaction-

Clinical efficacy of Budesonide Turbuhaler in pediatric patients with bronchial asthma -Evaluation of JPAC scores and parent/guardian satisfaction- - Clinical efficacy of Budesonide Turbuhaler in pediatric patients with bronchial asthma -Evaluation of JPAC scores and parent/guardian satisfaction-

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005155

Enrollment

100

Registered

2011-03-01

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma

Interventions

Budosonide turbuhaler (200 mcg) 1 inhlation, Twice daily, 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Outpatients with bronchial asthma aged between 5 and 15 years (2) Patients for whom both patient's and parent/guardian's written informed consent can be obtained Note: For patients who are too young to provide written informed consent, verbal assent of the patients confirmed by parent/guardian can be substituted. (3) Patients who have not received ICS therapy during the preceding three months (4) Patients with asthma poorly controlled over the preceding month (with a total JPAC score of 11 or less at the start of study) (including newly diagnosed patients)

Exclusion criteria

Exclusion criteria: (1) Patients given systemic steroid therapy within the preceding month (2) Patients unable to use Turbuhaler appropriately (judgment by physician) (3) Patients contraindicated for the study drug (4) Patients with any chronic respiratory disease other than asthma (5) Patients complicated by acute lower respiratory tract infection at the time of enrollment (6) Other patients judged by the physician to be inappropriate for this study

Design outcomes

Primary

Measure	Time frame
Improvement in JPAC (Japanese Pediatric Asthma Control Program) score	—

Secondary

Measure	Time frame
- Respiratory function - Parent/guardian satisfaction - Adherence - Fractional exhaled nitric oxide - Adverse events	—

Countries

Japan

Contacts

Public ContactShigemi Yoshihara

Dokkyo Medical University Department of Pediatrics

0282-86-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026